Lamellar Biomedical Ltd

12 articles about Lamellar Biomedical Ltd

• Lamellar Biomedical Expands its Product Formulation and Process Capabilities to Realise the Potential of its LAMELLASOME™ Nucleic Acid Transfer (NAT) technology

  3/27/2019

  The dedicated formulation and process facility will enable Lamellar to meet the need for increased capacity as its technology attracts growing interest from external partners and it progresses its own in-house development projects.

• Lamellar Biomedical Submits Patent for LAMELLASOME™ platform for the safe and effective delivery of nucleic acid based therapeutics

  11/1/2018

  Unique technology set to play a key role in the rapidly emerging gene therapy market

• Lamellar to introduce its LAMELLASOME™ technology for the safe and effective delivery of nucleic acid based therapeutics at BIO-Europe 2018 in Copenhagen

  10/29/2018

  Lamellar Biomedical Limited announces that Dr Alec McLean ,CEO, Dr Lynsey Howard (Head of  Preclinical) and Steven Porteous (Head of Clinical and Regulatory) will be attending BIO-Europe 2018 in Copenhagen to introduce potential partners and investors to its cutting-edge LAMELLASOME™ technology.

• Lamellar Biomedical Ltd Recruits First Patients Into Clinical Study Assessing LAMELLEYE For Treatment Of Dry Eye Disease

  5/31/2017

• Lamellar Biomedical Ltd Raises £5.75 Million In Series C Fund Raising Led By Invesco

  5/9/2017

• Lamellar Biomedical Ltd Raises £5.75 Million In Series C Fund Raising Led By Invesco

  5/8/2017

• Lamellar Biomedical Ltd And Beatson West of Scotland Cancer Centre Announce Recruitment Of First Patient In Clinical Study Assessing Visco-Ease For The Treatment Of Radiotherapy-Induced Xerostomia (RIX)

  3/29/2016

• Lamellar Biomedical Ltd Signs Agreement With Edinburgh Complex Fluids Partnership, University of Edinburgh, To Advance Research Into The Biophysical Properties Of Lamellasomes

  2/29/2016

• Lamellar Biomedical Ltd Release: Visco-ease Paper Published In Supportive Care Journal

  2/2/2016

• Lamellar Biomedical Ltd To Present At BIO-Europe 2015

  10/29/2015

• Lamellar Biomedical Ltd Closes £2.3 Million Investment Round

  7/28/2015

• Lamellar Biomedical Ltd Secures its First Orphan Drug Licence

  6/16/2011